Co-Authors
This is a "connection" page, showing publications co-authored by Roberto Tonelli and Massimo Girardis.
Connection Strength
1.543
-
Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study. Am J Respir Crit Care Med. 2021 09 15; 204(6):725-728.
Score: 0.242
-
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study. Pulmonology. 2021 Mar 22.
Score: 0.234
-
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study. Multidiscip Respir Med. 2021 Jan 15; 16(1):737.
Score: 0.231
-
Never Give Up: Lesson learned from a severe COVID-19 patient. Pulmonology. 2021 May-Jun; 27(3):257-260.
Score: 0.220
-
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620951043.
Score: 0.215
-
Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies. Clin Infect Dis. 2021 07 01; 73(1):e252-e255.
Score: 0.060
-
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
Score: 0.058
-
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
Score: 0.058
-
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford). 2020 12 01; 59(12):e147-e150.
Score: 0.057
-
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency. PLoS One. 2020; 15(11):e0239172.
Score: 0.057
-
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020 07 06; 11(1):3434.
Score: 0.056
-
Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
Score: 0.056